09:20 AM EDT, 06/04/2024 (MT Newswires) -- Fortrea Holdings ( FTRE ) said Tuesday that it has completed the divestiture of its Enabling Services segment, including Endpoint Clinical and Fortrea Patient Access, to an affiliate of Arsenal Capital Partners.

The final purchase price for the deal was $295 million paid at closing and $45 million payable upon completion of certain milestones.

Proceeds from the sale will be used to reduce Fortrea's ( FTRE ) debt, the company said.